Cargando…
A RNA-DNA Hybrid Aptamer for Nanoparticle-Based Prostate Tumor Targeted Drug Delivery
The side effects of radio- and chemo-therapy pose long-term challenges on a cancer patient’s health. It is, therefore, highly desirable to develop more effective therapies that can specifically target carcinoma cells without damaging normal and healthy cells. Tremendous efforts have been made in the...
Autores principales: | Leach, John C., Wang, Andrew, Ye, Kaiming, Jin, Sha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4813238/ https://www.ncbi.nlm.nih.gov/pubmed/26985893 http://dx.doi.org/10.3390/ijms17030380 |
Ejemplares similares
-
Aptamers for Targeted Drug Delivery
por: Ray, Partha, et al.
Publicado: (2010) -
Doxorubicin Loaded DNA Aptamer Linked Myristilated Chitosan Nanogel for Targeted Drug Delivery to Prostate Cancer
por: Atabi, Fereshteh, et al.
Publicado: (2017) -
Aptamer-Gated Nanoparticles for Smart Drug Delivery
por: Ozalp, Veli Cengiz, et al.
Publicado: (2011) -
Synthetic
Aptamer-Polymer Hybrid Constructs for Programmed
Drug Delivery into Specific Target Cells
por: Oh, Seung Soo, et al.
Publicado: (2014) -
Aptamer-Targeted DNA Nanostructures for Therapeutic
Delivery
por: Charoenphol, Phapanin, et al.
Publicado: (2014)